143
Participants
Start Date
May 20, 2024
Primary Completion Date
June 1, 2028
Study Completion Date
June 1, 2028
Biospecimen Collection
Undergo collection of blood samples
Letermovir
Given PO or IV
Children's Hospital of Philadelphia, Philadelphia
Alfred I duPont Hospital for Children, Wilmington
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
VCU Massey Comprehensive Cancer Center, Richmond
Nemours Children's Clinic-Jacksonville, Jacksonville
Children's Hospital of Alabama, Birmingham
The Children's Hospital at TriStar Centennial, Nashville
Saint Jude Children's Research Hospital, Memphis
Children's Hospital of Michigan, Detroit
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
University of Iowa/Holden Comprehensive Cancer Center, Iowa City
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Children's Hospital New Orleans, New Orleans
Medical City Dallas Hospital, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Methodist Children's Hospital of South Texas, San Antonio
UCSF Medical Center-Mission Bay, San Francisco
UCSF Benioff Children's Hospital Oakland, Oakland
Children's Oncology Group
NETWORK